Skip to content
Companies

Global Innovative Platforms

Breath-based disease tests for dogs and other animals

Raised to date

$157K

of $5.6M offered across 2 Form D filings

Still open
$5.4M
Investors
8
Last filed
Jun 4, 2026

About

Global Innovative Platforms Inc. (OTC: GIPL) develops non-invasive breath-based diagnostics for animal health through its VetBreath Analytics division. Its platform uses gas chromatography plus cloud-based AI to identify disease-specific volatile organic compounds in a shallow breath sample, returning results in about ten minutes with no blood draw or stool collection. The lead program is a canine heartworm breath test, running an eight-month study with researchers at Auburn University and Oklahoma State and using the shelter Big Dog Ranch Rescue as a high-volume sample collection partner. Additional breath signatures for intestinal parasites, feline disease, livestock and poultry conditions are in development.

Detects disease from a breath sample at parts-per-trillion sensitivity in minutes, where conventional heartworm antigen testing requires a stressful blood draw and cannot detect infection until roughly six months after exposure.

Funding

$5M round, first sold Jun 2026Nothing sold yetMay 20252026
Now
  • EquityFiled Jun 4, 2026Form D
    None sold/ $5M
  • EquityFiled Apr 8, 2026Form D
    $157K/ $600K

Product

VetBreath Dx Breath Analysis Platform

Veterinary diagnostic device

A point-of-care veterinary diagnostic system pairing a breath collection device with gas chromatography instrumentation (VOCAM+ and FROG platforms) and cloud AI that reads disease-specific volatile organic compound signatures.

  • Non-invasive breath sampling, no blood draw or stool sample
  • Gas chromatography reading volatile organic compounds down to parts per trillion
  • Cloud-based, continuously learning AI classification

Built for

Veterinary practices, animal shelters and rescues, and livestock and poultry operations

People on file